Late-onset neurodegenerative diseases--the role of protein insolubility

scientific article

Late-onset neurodegenerative diseases--the role of protein insolubility is …
instance of (P31):
scholarly articleQ13442814
review articleQ7318358

External links are
P356DOI10.1046/J.1469-7580.2000.19640609.X
P932PMC publication ID1468101
P698PubMed publication ID10923991
P5875ResearchGate publication ID12396386

P2093author name stringJohnson WG
P2860cites workSynphilin-1 associates with alpha-synuclein and promotes the formation of cytosolic inclusionsQ22009563
Mutation in the alpha-synuclein gene identified in families with Parkinson's diseaseQ27860459
Inhibition of caspase-1 slows disease progression in a mouse model of Huntington's diseaseQ28114818
Association of missense and 5'-splice-site mutations in tau with the inherited dementia FTDP-17Q28274687
NACP/alpha-synuclein immunoreactivity in fibrillary components of neuronal and oligodendroglial cytoplasmic inclusions in the pontine nuclei in multiple system atrophyQ28289929
Mapping of a gene for Parkinson's disease to chromosome 4q21-q23Q28295005
Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's diseaseQ29547175
Stabilization of alpha-synuclein secondary structure upon binding to synthetic membranesQ29617606
Structure/function in neuroprotection and apoptosis.Q30431508
Abnormal accumulation of NACP/alpha-synuclein in neurodegenerative disordersQ32121511
From computer simulations to human disease: emerging themes in protein foldingQ33630957
Neuropathologic overlap of progressive supranuclear palsy, Pick's disease and corticobasal degenerationQ34371240
Alternative conformations of amyloidogenic proteins govern their behaviorQ34387876
Familial progressive supranuclear palsy. Description of a pedigree and review of the literatureQ34719147
Autopsy-proven progressive supranuclear palsy in two siblingsQ34734443
Lewy bodies contain altered alpha-synuclein in brains of many familial Alzheimer's disease patients with mutations in presenilin and amyloid precursor protein genesQ35754459
The environmental dependency of protein folding best explains prion and amyloid diseasesQ36054435
Caspase-8 is required for cell death induced by expanded polyglutamine repeats.Q40961806
Both familial Parkinson's disease mutations accelerate alpha-synuclein aggregationQ40964871
Steroid hormones block amyloid fibril-induced 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) formazan exocytosis: relationship to neurotoxicity.Q40992053
Neurodegenerative disorders with extensive tau pathology: a comparative study and reviewQ41084709
Normal and pathological Tau proteins as factors for microtubule assembly.Q41379250
Harm's way: polyglutamine repeats and the activation of an apoptotic pathway.Q41644857
The alternative conformations of amyloidogenic proteins and their multi-step assembly pathwaysQ41728317
Polyglutamine-expanded human huntingtin transgenes induce degeneration of Drosophila photoreceptor neurons.Q45296540
Human recombinant NACP/alpha-synuclein is aggregated and fibrillated in vitro: relevance for Lewy body diseaseQ46084408
Abnormal distribution of the non-Abeta component of Alzheimer's disease amyloid precursor/alpha-synuclein in Lewy body disease as revealed by proteinase K and formic acid pretreatmentQ46198761
Alpha-synuclein immunoreactivity in glial cytoplasmic inclusions in multiple system atrophyQ47772222
The ubiquitin pathway in Parkinson's diseaseQ48015939
Accumulation of alpha-synuclein/NACP is a cytopathological feature common to Lewy body disease and multiple system atrophy.Q48342277
Accelerated in vitro fibril formation by a mutant alpha-synuclein linked to early-onset Parkinson disease.Q48353748
Synthetic filaments assembled from C-terminally truncated alpha-synuclein.Q48360396
Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions.Q48373564
Binding of alpha-synuclein to brain vesicles is abolished by familial Parkinson's disease mutation.Q48384247
Glial cytoplasmic inclusions in white matter oligodendrocytes of multiple system atrophy brains contain insoluble alpha-synuclein.Q48389356
Filamentous alpha-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies.Q48401512
Multiple-system atrophy: a new alpha-synuclein disease?Q48406192
Changes in presynaptic protein NACP/alpha-synuclein in an ischemic gerbil hippocampus.Q48466817
Reversible conversion of monomeric human prion protein between native and fibrilogenic conformations.Q54102352
Synchrotron X-ray studies suggest that the core of the transthyretin amyloid fibril is a continuous β-sheet helixQ57945110
Extensive axonal Lewy neurites in Parkinson's disease: a novel pathological feature revealed by alpha-synuclein immunocytochemistryQ64861825
Aggregates from mutant and wild-type alpha-synuclein proteins and NAC peptide induce apoptotic cell death in human neuroblastoma cells by formation of beta-sheet and amyloid-like filamentsQ64866811
P433issue4
P921main subjectneurodegenerationQ1755122
P304page(s)609-616
P577publication date2000-05-01
P1433published inJournal of AnatomyQ2108124
P1476titleLate-onset neurodegenerative diseases--the role of protein insolubility
P478volume196 ( Pt 4)

Reverse relations

cites work (P2860)
Q34340531Alpha synuclein aggregation: is it the toxic gain of function responsible for neurodegeneration in Parkinson's disease?
Q37253310Alzheimer's disease and blood-brain barrier function-Why have anti-beta-amyloid therapies failed to prevent dementia progression?
Q43256880Characterization of intrinsically disordered proteins with electrospray ionization mass spectrometry: conformational heterogeneity of alpha-synuclein
Q38609997Cognitive impairment in humanized APP×PS1 mice is linked to Aβ(1-42) and NOX activation.
Q28367378Conformational characterization of oligomeric intermediates and aggregates in beta-lactoglobulin heat aggregation
Q36772901Decreased blood-brain barrier P-glycoprotein function in the progression of Parkinson's disease, PSP and MSA.
Q33371063Differential regulation of wild-type and mutant alpha-synuclein binding to synaptic membranes by cytosolic factors
Q24544265Disulfide cross-linked protein represents a significant fraction of ALS-associated Cu, Zn-superoxide dismutase aggregates in spinal cords of model mice
Q24685507Dorfin localizes to the ubiquitylated inclusions in Parkinson's disease, dementia with Lewy bodies, multiple system atrophy, and amyotrophic lateral sclerosis
Q41969333Effects of urea and acetic acid on the heme axial ligation structure of ferric myoglobin at very acidic pH.
Q27027455Evaluation of traditional medicines for neurodegenerative diseases using Drosophila models
Q37351380Impaired mitochondrial energy production and ABC transporter function-A crucial interconnection in dementing proteopathies of the brain
Q34741685Learning cell biology as a team: a project-based approach to upper-division cell biology
Q50764411Mutant protein kinase Cgamma found in spinocerebellar ataxia type 14 is susceptible to aggregation and causes cell death.
Q43265626Neuroprotection in Parkinson's disease: love story or mission impossible?
Q42208600One-year follow-up of transgene expression by integrase-defective lentiviral vectors and their therapeutic potential in spinocerebellar ataxia model mice
Q34831541Programmed cell death in amyotrophic lateral sclerosis
Q34286115Protein misfolding and disease; protein refolding and therapy
Q35036503Recent advances in amyotrophic lateral sclerosis research
Q35577679The Hunt for a Cure for Parkinson’s Disease
Q45884689The emerging utility of animal models of chronic neurodegenerative diseases
Q24299624The novel cytosolic RING finger protein dactylidin is up-regulated in brains of patients with Alzheimer's disease
Q30503511Two-dimensional infrared correlation spectroscopy study of sequential events in the heat-induced unfolding and aggregation process of myoglobin
Q41141295α -Synuclein Modification in an ALS Animal Model

Search more.